These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22994732)

  • 1. Association between insulin-like growth factor-2 expression and prognosis after transcatheter arterial chemoembolization and octreotide in patients with hepatocellular carcinoma.
    Xiong ZP; Huang F; Lu MH
    Asian Pac J Cancer Prev; 2012; 13(7):3191-4. PubMed ID: 22994732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
    Song BC; Chung YH; Kim JA; Lee HC; Yoon HK; Sung KB; Yang SH; Yoo K; Lee YS; Suh DJ
    Cancer; 2001 Jun; 91(12):2386-93. PubMed ID: 11413529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Xiong ZP; Yang SR; Liang ZY; Xiao EH; Yu XP; Zhou SK; Zhang ZS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):386-90. PubMed ID: 15313674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients.
    Shim JH; Park JW; Kim JH; An M; Kong SY; Nam BH; Choi JI; Kim HB; Lee WJ; Kim CM
    Cancer Sci; 2008 Oct; 99(10):2037-44. PubMed ID: 19016764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
    Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
    World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of serum insulin-like growth factor-1 in hepatocellular carcinoma.
    Elmashad N; Ibrahim WS; Mayah WW; Farouk M; Ali LA; Taha A; Elmashad W
    Asian Pac J Cancer Prev; 2015; 16(2):613-9. PubMed ID: 25684496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
    Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
    J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib.
    Fu S; Chen S; Liang C; Liu Z; Zhu Y; Li Y; Lu L
    Oncotarget; 2017 Jun; 8(23):37855-37865. PubMed ID: 27911268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma.
    Wang B; Li F; Cheng L; Zhan Y; Wu B; Chen P; Shen J; Wu W; Ma X; Zhu J; Pan B; Guo W; Cheng Y
    Future Oncol; 2019 Mar; 15(8):827-839. PubMed ID: 30714399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
    Lee SW; Lee HL; Han NI; Jang JW; Bae SH; Choi JY; Yoon SK
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):81-88. PubMed ID: 27913882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization.
    Cho E; Kim HC; Lee JH; Jeong-Ju Yoo ; Choi WM; Cho YY; Lee MJ; Cho Y; Lee DH; Lee YB; Yu SJ; Kim YJ; Yoon JH; Chung JW; Kim CY; Lee HS
    PLoS One; 2014; 9(3):e90862. PubMed ID: 24595361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.